Bringing Innovations to European Patients

News & Events

Here you will find an overview of selected current and completed projects and undertakings of the IGES Group and its subsidiaries.

BIO-Europe 2024

BIO-Europe 2024

Panel at BIO-EUROPE: Start early, seek advice, talk to the HTA Agencies

BIO Japan 2024

Meet the IGES Pharma experts at the second largest industry event of its kind for the biopharmaceutical sector

Panel at the BIO International 2024

Panel at the BIO International 2024

Europe's Policy Environment and the Impact on the Biotech Sector

BIO International 2024

BIO International 2024

IGES at the BIO in San Diego

BIO-Europe Spring 2024

BIO-Europe Spring 2024

IGES at the BIO-Europe Spring 2024

Current Status EU-HTA

Current Status EU-HTA

Current documents on the EU-HTA process and opportunity to provide feedback

EU-HTA: 12th January 2025

EU-HTA: 12th January 2025

Pharmaceuticals: The countdown to EU-HTA runs

IGES at ISPOR 2023 in Copenhagen

IGES at ISPOR 2023 in Copenhagen

HTA, Market Access and Strategy in Europe, EU-HTA Stakeholder

BIO EUROPE 2023

BIO EUROPE 2023

EU HTA harmonisation under time pressure: discussion at the biotech congress "BIO Europe 2023"

IGES France Pharma Consulting

IGES France Pharma Consulting

IGES sets up a new subsidiary in France – IGES France Pharma Consulting

Synergus RWE

Synergus RWE

IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist